Article

Impact of buttermilk consumption on plasma lipids and surrogate markers of cholesterol homeostasis in men and women

STELA Dairy Research Center, Laval University, Quebec, Canada
Nutrition, metabolism, and cardiovascular diseases: NMCD (Impact Factor: 3.88). 06/2013; 23(12). DOI: 10.1016/j.numecd.2013.03.003
Source: PubMed

ABSTRACT Sphingolipids (SL) are important components of the milk fat globule membrane (MFGM) found in buttermilk. While studies in animal models suggest that dietary SL may have cholesterol-lowering properties, data in human are lacking. The aim of this study was to investigate the impact of buttermilk consumption on plasma lipids and surrogate markers of cholesterol (C) homeostasis in humans.
Men and women (n = 34) with serum LDL-C <5.0 mmol/L at screening (mean LDL-C = 3.8 mmol/L) were recruited in this double-blinded randomized crossover placebo controlled study. Their diets were supplemented with 45 g/d of buttermilk and with 45 g/d of a macro/micronutrient matched placebo (4 weeks each in random order). Serum lipid concentrations and surrogate markers of cholesterol homeostasis were measured post diet and compared using mixed models for repeated measures. Consumption of buttermilk led to reduction in serum cholesterol (-3.1%, P = 0.019), LDL-C (-3.1%, P = 0.057) and triacylglycerol (-10.7%, P = 0.007). Buttermilk consumption increased plasma lathosterol concentrations (+12.1%, P = 0.001), but multiple regression analysis indicated that variations in β-sitosterol concentrations (P = 0.002) were the only significant predictor of the LDL-C response to buttermilk consumption.
Buttermilk consumption may be associated with reduced cholesterol concentrations in men and women, primarily through inhibition of intestinal absorption of cholesterol.
This trial is registered at clinicaltrials.gov as NCT01248026.

Download full-text

Full-text

Available from: Valérie Conway, Apr 27, 2015
1 Follower
 · 
139 Views
  • Source
    • "Meanwhile, the biological effects of the whole sweet buttermilk matrix remain poorly understood. A few well-controlled clinical trials provide support for the buttermilk health-benefits hypothesis (Baumgartner et al., 2013; Conway et al., 2013, 2014). The purpose of this review is to present recent advances in sweet buttermilk utilization and examine its status as a high-value by-product of dairy processing. "
    03/2014; 4(2):44-51. DOI:10.2527/af.2014-0014
  • Source
    • "In conclusion, data from this randomized trial reports that short-term supplementation with buttermilk (45 g/d)dpossibly through its high MFGM content and its effect on the ACE systemdlowers SBP in normotensive individuals. Combined with the buttermilk-induced reduction in plasma levels of total cholesterol and TGs in the same individuals [9], these data indicate that buttermilk may represent a new safe food modality to manage blood cholesterol and BP as part of healthy eating. Further studies are required to validate these observations. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Milk fat globule membrane (MFGM) found in buttermilk is rich in unique bioactive proteins. Several studies suggest that MFGM proteins possess biological activities such as cholesterol-lowering, antiviral, antibacterial, and anticancer properties, but data in humans are lacking. Furthermore, to our knowledge, no study has yet investigated the antihypertensive potential of MFGM proteins from buttermilk. The aim of this study was to investigate the effects of buttermilk consumption on blood pressure and on markers of the renin-angiotensin-aldosterone (RAS) system in humans. Men and women (N = 34) with plasma low-density lipoprotein cholesterol < 5 mmol/L and normal blood pressure (< 140 mm Hg) were recruited in this randomized, double-blind, placebo-controlled, crossover study. Their diets were supplemented with 45 g/d of buttermilk and with 45 g/d of a macro-/micronutrient-matched placebo in random order (4 wk for each diet). Buttermilk consumption significantly reduced systolic blood pressure (-2.6 mm Hg; P = 0.009), mean arterial blood pressure (-1.7 mm Hg; P = 0.015), and plasma levels of the angiotensin I-converting enzyme (-10.9%; P = 0.003) compared with the placebo, but had no effect on plasma concentrations of angiotensin II and aldosterone. Short-term buttermilk consumption reduces blood pressure in normotensive individuals.
    Nutrition 10/2013; 30(1). DOI:10.1016/j.nut.2013.07.021 · 3.05 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The incidence of the metabolic syndrome (MetS) and type 2 diabetes (T2D) is increasing worldwide. Evidence supports a negative relationship between the consumption of dairy products and risk of MetS and T2D. Dairy proteins are known to have a directly beneficial effect on hypertension, dyslipidemia, and hyperglycemia, but a detailed understanding of the underlying mechanisms is missing. It has been confirmed by observations that the insulinotropic effect of dairy proteins is associated with the amino acid composition; in particular branched-chain amino acids (BCAA) seem to be of vital importance. Dairy protein-derived peptides may also contribute to the insulinotropic effect via dipeptidyl peptidase-4 (DPP-4) inhibitory activity, and may lower the blood pressure (BP). The lipid metabolism may be improved by whey protein (WP), which acts to reduce the postprandial triglyceride (TG) response. The effect of dairy fat is much more controversial because of the potentially harmful effect exerted by saturated fatty acid (SFA) on metabolic health. Recent observations suggest less adverse effects of SFA on metabolic health than previous assumed. However, little is known about dairy lipid fractions belonging to the groups of monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), and phospholipids (PL). Dairy fat seems to act differently depending on the dairy product and the composition of macronutrients in the meal. Therefore, for a better understanding of the mechanisms behind the dairy protein and fat effect on MetS, we suggest that more human studies should be carried out to clarify the interactions of dairy protein and fat with macronutrients in the meal and other dairy components, such as micronutrients and microorganisms from fermented products.
    The Review of Diabetic Studies 01/2014; 11(2):153-66. DOI:10.1900/RDS.2014.11.153
Show more